CNTB

Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Ltd (CNTB) has 6 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 1, 2026.

Insiders have net bought $4.4M over the trailing 6 months. The largest single insider purchase in this window was $4.0M by Director Huang James on Mar 31, 2026.

  • Industry:Biotechnology
  • CEO:Barry D. Quart
  • Employees:64
  • HQ:San Diego, CA, US
  • IPO:2021-03-19

Insider Buying

$4.4M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$138.8M

latest known value

Source
Purchase$372KJun 2SEC ↗
Huang JamesFirst filing
Purchase$4.0MApr 1SEC ↗

Related companies

Connect Biopharma Holdings Ltd is in the Healthcare sector.